previous compound ID: 2068 next compound
InChIKey: SEEPANYCNGTZFQ-UHFFFAOYSA-N
SMILES: C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"R Robert" "JW Hanrahan" "GW Carlile" "D Rotin" "DY Thomas" "J Liao" "E Matthes" "J Goepp" "SD Macknight" "B Kus"

chemical graph of compound 2068





CID is 5215
synonyms found at PubChem are:
sulfadiazine, 68-35-9, Sulphadiazine, Sulfapyrimidine, Sulfadiazin, Sulfazine, Sulfadiazene, Liquadiazine, Sulfapyrimidin, Adiazin, Adiazine, Debenal, Pyrimal, 2-Sulfanilamidopyrimidine, Cremodiazine, Spofadrizine, Theradiazine, Cremotres, Deltazina, Diazolone, Eskadiazine, Microsulfon, Neotrizine, Palatrize, Piridisir, Quadetts, Quadramoid, Sanodiazine, Sterazine, Sulfatryl, Sulfolex, Sulfonsol, Terfonyl, Trifonamide, Truozine, Diazin, Diazyl, Neazine, Pirimal, Sulfose, Trisem, Sulfanilamidopyrimidine, Honey diazine, Lipo-Levazine, Tri-Sulfameth, Triple Sulfas, Coco-Diazine, Lipo-Diazine, Metha-Meridiazine, Sulfadiazinum, Diazovit, Sulfadiazina, Sulphadiazine E, Sulfapirimidin, Di-Azo-Mul, Thi-Di-Mer, 2-Sulfanilylaminopyrimidine, Codiazine, Silvadene, Pecta-diazine, suspension, Benzenesulfonamide, 4-amino-N-2-pyrimidinyl-, Solfadiazina, CocoDiazine, Solfadiazina [DCIT], RP 2616, 4-amino-N-(pyrimidin-2-yl)benzenesulfonamide, Pyrimidine, 2-sulfanilamido-, 2-Sulfanilamidopyrimidin, Sulfapyrimidin [German], Zinc Sulfadiazine, 2-Sulfapyrimidine, Sulfonamides Duplex, Sulfadiazinum [INN-Latin], Sulfadiazina [INN-Spanish], 4-AMINO-N-2-PYRIMIDINYLBENZENESULFONAMIDE, N(1)-2-pyrimidylsulfanilamide, N(1)-2-pyrimidinylsulfanilamide, Pecta-Diazine, 2-Sulfanilamidopyrimidin [German], S.N. 112, 4-amino-N-pyrimidin-2-ylbenzenesulfonamide, A 306, A-306 (VAN), N(sup 1)-2-Pyrimidinylsulfanilamide, Sulfadiazine (TN), Thermazene, N1-2-Pyrimidinylsulfanilamide, Sildaflo, CHEBI:9328, Sulfadiazine [USAN:INN:JAN], Sulfanilamide, N(sup 1)-2-pyrimidinyl-, rBPI21 & Sulfa, N(sup1)-2-Pyrimidylsulfanilamide, Sulfanilamide, N1-2(1H)-pyrimidinylidene-, 4-amino-N-pyrimidin-2-yl-benzenesulfonamide, N1-(Pyrimidin-2-yl)sulfanilamide, Sulfanilamide, N1-2-pyrimidinyl-, UNII-0N7609K889, A-306, N(sup1)-2-Pyrimidinylsulfanilamide, EINECS 200-685-8, NSC 35600, 2-Sulfanilamido-pyrimidine, 4-amino-N-(pyrimidin-2-yl)benzene-1-sulfonamide, CHEMBL439, N1-2-Pyrimidylsulfanilamide, BRN 0235192, C10H10N4O2S, CRL-8131 & Sulfadiazine, Sulfadiazine (JAN/USP/INN), Triple sulfa, 4-Amino-N-2-pyrimidinyl-benzenesulfonamide, AI3-01047, S. N. 112, 4-Amino-N-(2-pyrimidinyl)benzenesulfonamide, N-(2-Pyrimidinyl)sulfanilamide, SULFADIAZINE SODIUM, SEEPANYCNGTZFQ-UHFFFAOYSA-N, Trisulfapyrimidine, oral suspension, NSC35600, CAS-68-35-9, NCGC00016305-01, 0N7609K889, [(4-aminophenyl)sulfonyl]pyrimidin-2-ylamine, NSC117870, Recombinant bactericidal/permeability-increasing protein & Sulfadiazine, Sulfadiazine, Zinc, 141582-64-1, SMR000059113, SR-01000002973, Neotrizine (TN), Lantrisul (TN), Sulfadiazine,(S), Sulfaloid (TN), Sulfadiazine [USP:INN:BAN:JAN], Terfonyl (TN), DRG-0214, Prestwick_428, Sulfose (TN), Triple Sulfa (TN), Triple Sulfas (TN), Triple Sulfoid (TN), Spectrum_000986, Sulfadiazina Reig Jofre, Sulfacombin (Salt/Mix), AC1L1JUR, Prestwick0_000023, Prestwick1_000023, Prestwick2_000023, Prestwick3_000023, Spectrum2_001319, Spectrum3_001362, Spectrum4_000342, Spectrum5_000992, Sulfonamides Duplex (TN), Sulfa-Triple #2 (TN), D05LKP, Epitope ID:140083, AC1Q51XM, AC1Q6W1E, Sulfadiazine, >=99.0%, DSSTox_CID_24130, DSSTox_RID_80105, DSSTox_GSID_44130, Oprea1_081078, SCHEMBL24176, BSPBio_000085, BSPBio_002884, KBioGR_000743, KBioSS_001466, 5-25-10-00067 (Beilstein Handbook Reference), MLS000069423, MLS006011457, DivK1c_000543, SPECTRUM1500546, SPBio_001417, SPBio_002006, BPBio1_000095, WLN: T6N CNJ BMSWR DZ, DTXSID7044130, CTK7D7930, HMS501L05, KBio1_000543, KBio2_001466, KBio2_004034, KBio2_006602, KBio3_002104, MolPort-000-629-738, NINDS_000543, HMS1568E07, HMS1921A13, HMS2090P09, HMS2092I15, HMS2095E07, HMS2235D19, HMS3371L19, HMS3655I10, HMS3712E07, Pharmakon1600-01500546, ZINC120319, ALBB-014888, BCP12140, HY-B0273, Tox21_110360, BBL013169, BDBM50166571, CCG-39257, MFCD00006065, NSC-35600, NSC757324, s1770, SBB007604, SBB057674, STK317797, 2-(p-Aminobenzenesulfonamido)pyrimidin, AKOS000119073, CS-2263, DB00359, KS-1144, MCULE-4577338719, NE10425, NSC-757324, RP17586, 2-(4-Aminobenzenesulfonamido)pyrimidine, 4-amino-N-2-pyrimidylbenzenesulfonamide, IDI1_000543, N1-2(1H)-pyrimidinylidene-sulfanilamide, NCGC00016305-02, NCGC00016305-03, NCGC00016305-04, NCGC00016305-05, NCGC00016305-06, NCGC00016305-10, NCGC00023291-03, NCGC00023291-04, SULFADIAZINE (TRISULFAPYRIMIDINES), Sulfanilamide, N1-2-pyrimidinyl-(8CI), 2-(4-Aminobenzenesulfonylamino)pyrimidine, AC-26817, H458, ST059447, Sulfanilamide, N1-2-pyrimidinyl- (8CI), ZB004097, Mixture of sulfadiazine, and sulfamethazine, SBI-0051520.P003, AB2000282, KB-295527, LS-147838, 4-[[(Pyrimidin-2-yl)amino]sulfonyl]aniline, 4-Amino-N-2-pyrimidinyl- benzenesulfonamide, AB00052095, Benzenesulfonamide,4-amino-N-2-pyrimidinyl-, FT-0674741, R3929, S0579, ST51006797, TL80073596, 4-amino-N-(2-pyrimidinyl) benzenesulfonamide, 4-Amino-n-(2-pyrimidinyl)benzene-sulfonamide, 4-Amino-N-(2-pyrimidinyl)benzenesulfonamide #, 68S359, C07658, D00587, Trisulfapyrimidine, oral suspension (Salt/Mix), AB00052095-13, AB00052095-14, AB00052095_15, AB00052095_16, Benzenesulfonamide, 4-amino-N-(2-pyrimidinyl)-, Sulfadiazine, VETRANAL(TM), analytical standard, Q-201759, SR-01000002973-2, SR-01000002973-3, BRD-K32273377-001-05-4, BRD-K32273377-001-09-6, I01-15838, F1657-1720, I14-110269, Sulfadiazine, certified reference material, TraceCERT(R), Z271004844, Mixture of sulfadiazine, sulfamerazine, and sulfamethazine, Sulfadiazine, European Pharmacopoeia (EP) Reference Standard, Sulfadiazine, United States Pharmacopeia (USP) Reference Standard, Adiazin, Adiazine, Debenal, Liquadiazine, Microsulfon, Sulfazine, Sulfolex, Sulfadiazine, Sulfadiazine, Pharmaceutical Secondary Standard; Certified Reference Material, Sulfadiazine for identification of impurity F, European Pharmacopoeia (EP) Reference Standard